{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-005454","form_type":"8-K","ticker":"OCGN","cik":"0001372299","company_name":"Ocugen, Inc.","filed_at":"2026-01-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.933661+00:00","generated_at":"2026-05-16T09:16:01.432824+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Ocugen prices $22.5M common stock offering at $1.50/share; led by RTW Investments","bullets":["Priced 15M shares of common stock at $1.50/share for gross proceeds of $22.5M; net proceeds ~$20.8M.","Offering led by RTW Investments with participation from new and existing investors; expected to close Jan 22, 2026.","Proceeds to be used for general corporate purposes, capital expenditures, working capital, and G&A.","Oppenheimer & Co. acting as sole book-running manager for the offering."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-005454","json":"https://secwatch.observer/filing/0001104659-26-005454.json","markdown":"https://secwatch.observer/filing/0001104659-26-005454.md","text":"https://secwatch.observer/filing/0001104659-26-005454.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1372299/000110465926005454/0001104659-26-005454-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1372299/000110465926005454/tm263710d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T09:16:01.432824+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"07be7b1eacd9941be244a1a35837a9da1b41ed4e","claim":"Ocugen, Inc. entered into Underwriting Agreement with Oppenheimer & Co. Inc. valued at 15,000,000 shares of common stock at $1.50 per share, net proceeds approximately $20.8 million (effective 2026-01-20).","evidence_excerpt":"On January 20, 2026, Ocugen, Inc. (the “ Company ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with Oppenheimer & Co. Inc. (the “ Underwriter ”), pursuant to which the Company agreed to issue and sell to the Underwriter, in an offering (the “ Offering ”) 15,000,000 shares of the Company’s common stock, par value $0.01 per share (the “ Common Stock ”), at an offering price of $1.50 per share (the “ Offering Price ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1372299/000110465926005454/0001104659-26-005454-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"Oppenheimer & Co. Inc."},{"label":"Value","value":"15,000,000 shares of common stock at $1.50 per share, net proceeds approximately $20.8 million"},{"label":"Effective","value":"2026-01-20"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}